Auf dieser Seite
PCRX Pacira BioSciences, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 4, 2026
$25,21
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$18,8052-Wochen-Tief
$27,6652-Wochen-Hoch
Marktkapitalisierung (MRQ)
$1.00B
P/E (TTM)
70.0
EPS (TTM)
$0.36
Umsatz (TTM)
$746M
Ihre Abzeichen
52W-Spanne
$19–$28
Analystenbewertung
BUY
Kursziel
$30
P/E
70.0
ROE
2.0%
Nettogewinnmarge
2.0%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
PCRX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$25.21
Marktkapitalisierung (MRQ)
$1.00B
P/E (TTM)
70.0
EPS (TTM)
$0.36
Umsatz (TTM)
$746M
ROE (TTM)
2.0%
Verschuldungsgrad (MRQ)
0.5
52W-Spanne
$19–$28
PCRX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$726M2016-12-31 → 2025-12-31
EPS$0.162016-12-31 → 2025-12-31
Freier Cashflow$137M2016-12-31 → 2025-12-31
Nettogewinnmarge2.0%2016-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | PCRX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 70.05-Jahres-Durchschnitt ≈74.0 | ≈74.0 | · | · | |
| P/S (TTM) | 1.35-Jahres-Durchschnitt ≈2.5 | ≈2.5 | · | · | |
| K/B (MRQ) | 1.55-Jahres-Durchschnitt ≈2.1 | ≈2.1 | 3.7 | Unterbewertet | |
| EV / EBITDA (TTM) | 10.6 | · | · | · | |
| Kurs / FCF (TTM) | 5.65-Jahres-Durchschnitt ≈14.6 | ≈14.6 | · | · | |
| Kurs / Cashflow (TTM) | 5.35-Jahres-Durchschnitt ≈11.1 | ≈11.1 | · | · | |
| EV / Umsatz (TTM) | 1.5 | · | · | · | |
| EV / FCF (TTM) | 6.2 | · | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 2.65-Jahres-Durchschnitt ≈9.5 | ≈9.5 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | PCRX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | 2.7%5-Jahres-Durchschnitt ≈10.3% | ≈10.3% | -2342.9% | Spitzenklasse | |
| EBITDA-Marge (TTM) | 14.1%5-Jahres-Durchschnitt ≈21.0% | ≈21.0% | -1487.9% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | 2.4%5-Jahres-Durchschnitt ≈6.0% | ≈6.0% | -414.1% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | 2.0%5-Jahres-Durchschnitt ≈4.3% | ≈4.3% | -1320.1% | Spitzenklasse | |
| ROA (TTM) | 1.1%5-Jahres-Durchschnitt ≈0.01% | ≈0.01% | -34.1% | Spitzenklasse | |
| ROE (TTM) | 2.0%5-Jahres-Durchschnitt ≈0.14% | ≈0.14% | -39.7% | Spitzenklasse | |
| ROIC | 0.75%5-Jahres-Durchschnitt ≈2.2% | ≈2.2% | -30.5% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | PCRX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 0.5 | · | 0.3 | Hohe Verschuldung | |
| Liquiditätsgrad (MRQ) | 5.05-Jahres-Durchschnitt ≈3.4 | ≈3.4 | 10.1 | Geringe Liquidität | |
| Quick Ratio (MRQ) | 3.15-Jahres-Durchschnitt ≈2.6 | ≈2.6 | 9.0 | Geringe Liquidität | |
| Langfristige Schulden / Eigenkapital (MRQ) | 0.5 | · | 0.3 | Hohe Verschuldung |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | PCRX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 3.6%5-Jahres-Durchschnitt ≈11.6% | ≈11.6% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 2.9%5-Jahres-Durchschnitt ≈9.4% | ≈9.4% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 11.1% | · | · | · | |
| EPS YoY (EPS VjV) | 161.8%5-Jahres-Durchschnitt ≈8.8% | ≈8.8% | · | · | |
| Net Income YoY (Nettogewinn YoY) | 163.7%5-Jahres-Durchschnitt ≈10.2% | ≈10.2% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | -22.2% | · | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | -45.5% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | -23.8% | · | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | -45.4% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | PCRX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.55-Jahres-Durchschnitt ≈0.4 | ≈0.4 | 0.2 | Spitzenklasse | |
| Inventory Turnover (Lagerumschlag) | 1.15-Jahres-Durchschnitt ≈1.6 | ≈1.6 | · | · | |
| Receivables Turnover (Forderungsumschlag) | 6.15-Jahres-Durchschnitt ≈6.7 | ≈6.7 | 11.6 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$880.5K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-2.3%
Nächster Bericht
Nov 04, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 3, 2026 | $0.73 | $0.66 | 10.6% |
| 31. März 2026 | Mai 6, 2026 | $0.60 | $0.57 | 4.4% |
| 31. Dezember 2025 | $0.57 | $0.92 | -38.2% | |
| 30. September 2025 | $0.70 | $0.66 | 5.3% | |
| 30. Juni 2025 | $0.74 | $0.72 | 2.1% | |
| 31. März 2025 | $0.62 | $0.61 | 2.0% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $726M | $701M | $675M | $667M | $542M | $430M | $421M | $337M | $287M | $276M | $249M | $198M | |
| Cost of Revenue | $150M | $170M | $185M | $199M | $140M | $117M | $107M | $87M | $88M | $110M | $72M | $77M | |
| R&D Expense | $117M | $82M | $76M | $85M | $56M | $59M | $72M | $56M | $57M | $46M | $29M | $19M | |
| SG&A Expense | $369M | $294M | $269M | $255M | $199M | $194M | $201M | $177M | $161M | $153M | $139M | $107M | |
| Operating Expenses | $707M | $774M | $587M | $607M | $452M | $383M | $411M | $321M | $312M | $308M | $240M | $203M | |
| Operating Income | $19M | $-73M | $88M | $60M | $90M | $46M | $10M | $16M | $-25M | $-32M | $9M | $-5M | |
| Interest Expense | · | · | $20M | $40M | $32M | $26M | $24M | $22M | $18M | $7M | $8M | $8M | |
| Interest Income | $23M | $20M | $11M | $5M | $896.0K | $5M | $7M | $6M | $4M | $1M | $678.0K | $382.0K | |
| Other Non-op | $-7M | $-373.0K | $-186.0K | $-11M | $-3M | $3M | $-5M | $-888.0K | $167.0K | $-82.0K | $-165.0K | $-159.0K | |
| Pretax Income | $17M | $-63M | $62M | $13M | $56M | $20M | $-11M | $-425.0K | $-42M | $-38M | $2M | $-14M | |
| Income Tax | $10M | $36M | $20M | $-3M | $14M | $-125M | $268.0K | $46.0K | $140.0K | $105.0K | $264.0K | $173.0K | |
| Net Income | $7M | $-100M | $42M | $16M | $42M | $146M | $-11M | $-471.0K | $-43M | $-38M | $2M | $-14M | |
| EPS (Basic) | $0.16 | $-2.15 | $0.91 | $0.35 | $0.95 | $3.41 | $-0.27 | $-0.01 | $-1.07 | $-1.02 | $0.05 | $-0.39 | |
| EPS (Diluted) | $0.16 | $-2.15 | $0.89 | $0.34 | $0.92 | $3.33 | $-0.27 | $-0.01 | $-1.07 | $-1.02 | $0.04 | $-0.39 | |
| Shares (Basic) | 44,566,000 | 46,245,000 | 46,222,000 | 45,521,000 | 44,262,000 | 42,671,000 | 41,513,000 | 40,911,000 | 39,806,000 | 37,236,000 | 36,540,000 | 35,299,000 | |
| Shares (Diluted) | 45,042,000 | 46,245,000 | 51,979,000 | 46,538,000 | 45,630,000 | 43,682,000 | 41,513,000 | 40,911,000 | 39,806,000 | 37,236,000 | 41,301,000 | 35,299,000 | |
| EBITDA | $110M | $5M | $163M | $152M | $118M | $66M | $30M | $29M | $-11M | $-19M | $21M | $5M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $159M | $277M | $153M | $104M | $586M | $100M | $78M | $133M | $54M | $36M | $54M | $38M | |
| Short-term Investments | $80M | $208M | $125M | $185M | $71M | $422M | $214M | $251M | $257M | $137M | $102M | $119M | |
| Receivables | $124M | $113M | $106M | $98M | $96M | $53M | $48M | $38M | $32M | $30M | $26M | $22M | |
| Inventory | $153M | $125M | $104M | $96M | $99M | $65M | $58M | $49M | $41M | $31M | $62M | $29M | |
| Prepaid Expense | $33M | $22M | $22M | $15M | $15M | $12M | $11M | $8M | $7M | $9M | $6M | $4M | |
| Current Assets | $548M | $745M | $510M | $498M | $866M | $652M | $409M | $478M | $391M | $243M | $253M | $214M | |
| PP&E (Net) | $141M | $167M | $174M | $184M | $188M | $137M | $105M | $109M | $107M | $101M | $90M | $61M | |
| PP&E (Gross) | $278M | $300M | $309M | $301M | $274M | $215M | $180M | $170M | $156M | $139M | $115M | $81M | |
| Accum. Depreciation | $138M | $133M | $135M | $117M | $85M | $78M | $75M | $62M | $49M | $38M | $25M | $20M | |
| Goodwill | $20M | $0 | $163M | $163M | $145M | $100M | $100M | $62M | $55M | $47M | $31M | $24M | |
| Intangibles | $368M | $426M | $483M | $541M | $624M | $97M | $104M | $0 | · | $0 | $81.0K | $403.0K | |
| Other Non-current Assets | · | · | · | · | · | · | · | $657.0K | $825.0K | $624.0K | $406.0K | $3M | |
| Total Assets | $1.26B | $1.55B | $1.57B | $1.68B | $2.08B | $1.27B | $831M | $689M | $628M | $391M | $388M | $326M | |
| Accounts Payable | $15M | $19M | $16M | $15M | $11M | $10M | $13M | $14M | $15M | $8M | $9M | $7M | |
| Accrued Liabilities | $96M | $80M | $64M | $90M | $128M | $71M | $70M | $46M | $41M | $37M | $35M | $28M | |
| Current Liabilities | $121M | $310M | $97M | $148M | $521M | $253M | $108M | $61M | $56M | $45M | $150M | $140M | |
| Capital Leases | $36M | $45M | $55M | $65M | $72M | $71M | $41M | $0 | · | · | · | · | |
| Deferred Tax | $4M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $21M | $17M | $14M | $10M | $20M | $4M | $2M | $17M | $16M | $19M | $11M | $5M | |
| Total Liabilities | $572M | $775M | $704M | $906M | $1.34B | $655M | $476M | $368M | $349M | $172M | $169M | $155M | |
| Long-term Debt | $372M | $585M | $522M | $689M | · | · | · | · | · | $109M | $104M | $103M | |
| Total Debt | $372M | · | · | · | · | · | · | · | · | $119M | $119M | $120M | |
| Common Stock | $48.0K | $47.0K | $46.0K | $46.0K | $45.0K | $44.0K | $42.0K | $41.0K | $41.0K | $37.0K | $37.0K | $36.0K | |
| Paid-in Capital | $1.06B | $1.01B | $977M | $924M | $942M | $873M | $754M | $710M | $669M | $565M | $527M | $481M | |
| Retained Earnings | $-199M | $-206M | $-107M | $-149M | $-212M | $-254M | $-399M | $-388M | $-389M | $-346M | $-308M | $-310M | |
| Treasury Stock | $177M | $25M | $0 | · | · | · | · | · | · | · | · | · | |
| AOCI | $4M | $343.0K | $247.0K | $-380.0K | $167.0K | $318.0K | $322.0K | $-280.0K | $-454.0K | $-30.0K | $-52.0K | $-80.0K | |
| Stockholders' Equity | $693M | $778M | $870M | $775M | $730M | $620M | $355M | $321M | $279M | $219M | $218M | $171M | |
| Liabilities + Equity | $1.26B | $1.55B | $1.57B | $1.68B | $2.08B | $1.27B | $831M | $689M | $628M | $391M | $388M | $326M | |
| Shares Outstanding | 41,116,739 | 47,078,000 | 46,481,000 | 45,928,000 | 44,734,000 | 43,637,000 | 41,908,148 | 41,222,799 | 40,668,877 | 37,480,952 | 36,848,319 | 36,150,620 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $91M | $79M | $76M | $92M | $29M | $20M | $20M | $13M | $14M | $13M | $11M | $10M | |
| Stock-based Comp | $58M | $51M | $48M | $48M | $42M | $40M | $34M | $32M | $32M | $31M | $33M | $25M | |
| Deferred Tax | $6M | $21M | $16M | $-8M | $11M | $-127M | $-2M | $0 | $0 | · | · | · | |
| Amort. of Intangibles | $57M | $57M | $57M | $57M | $14M | $8M | $6M | $0 | $0 | $100.0K | $300.0K | $800.0K | |
| Restructuring | $4M | $9M | $1M | $0 | $0 | $-38.0K | $847.0K | $2M | · | · | · | · | |
| Other Non-cash | $-10M | $138M | $-26M | $-2M | $2M | $-2M | $30M | $4M | $15M | $27M | $-18M | $4M | |
| Operating Cash Flow | $152M | $189M | $155M | $145M | $126M | $77M | $71M | $49M | $18M | $33M | $28M | $27M | |
| CapEx | $15M | $11M | $15M | $30M | $46M | $38M | $10M | $15M | $19M | $25M | $40M | $23M | |
| Investing Cash Flow | $99M | $-83M | $78M | $-225M | $-21M | $-278M | $-128M | $21M | $-224M | · | · | · | |
| Debt Issued | · | · | · | · | · | · | · | · | · | $-4.0K | $-1M | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $-4.0K | $-1M | · | |
| Stock Repurchased | $148M | $25M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $-148M | $-25M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-370M | $17M | $-183M | $-402M | $381M | $222M | $4M | $9M | $224M | · | · | · | |
| Net Change in Cash | $-118M | $123M | $49M | $-481M | $486M | $22M | $-54M | $78M | · | · | · | · | |
| Taxes Paid | $9M | $11M | $4M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $137M | $179M | $139M | $115M | $80M | $39M | $60M | $34M | $-1M | $9M | $-12M | $4M | |
| Levered FCF | · | · | $126M | $67M | $56M | $-147M | $36M | $10M | $-20M | $2M | $-19M | $-5M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.6% | · | 13.0% | 9.0% | 16.6% | 10.8% | 2.5% | 4.7% | -8.7% | -11.6% | 3.8% | -2.6% | |
| Net Margin | 0.97% | · | 6.2% | 2.4% | 7.8% | 33.9% | -2.6% | -0.14% | -14.9% | -13.7% | 0.75% | -6.9% | |
| Pretax Margin | 2.3% | · | 9.1% | 2.0% | 10.4% | 4.7% | -2.5% | -0.13% | -14.8% | -13.7% | 0.85% | -6.9% | |
| EBITDA Margin | 15.2% | · | 24.2% | 22.7% | 21.9% | 15.4% | 7.1% | 8.6% | -3.9% | -6.9% | 8.4% | 2.5% | |
| ROA | 0.50% | -6.4% | 2.6% | 0.85% | 2.5% | 13.8% | -1.5% | -0.07% | -8.4% | -9.7% | 0.52% | -5.5% | |
| ROE | 0.97% | -13.0% | 4.9% | 2.1% | 5.8% | 24.2% | -3.1% | -0.15% | -17.1% | -17.3% | 0.95% | -12.9% | |
| ROIC | 0.75% | -14.9% | 6.9% | 9.3% | 9.2% | 54.2% | 3.0% | 5.5% | -8.9% | -9.5% | 2.5% | -1.8% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 2.4 | 5.2 | 3.4 | 1.7 | 2.6 | 3.8 | 7.9 | 7.0 | 5.4 | 1.7 | 1.5 | |
| Quick Ratio | 3.0 | 1.9 | 3.9 | 2.6 | 1.4 | 2.3 | 3.2 | 6.9 | 6.1 | 4.5 | 1.2 | 1.3 | |
| Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | 0.5 | 0.5 | 0.7 | |
| LT Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | 4.3 | 1.5 | 2.8 | 1.8 | 0.4 | 0.7 | -1.4 | -4.5 | 1.2 | -0.6 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | · | 0.4 | 0.4 | 0.3 | 0.4 | 0.6 | 0.5 | 0.6 | 0.7 | 0.7 | 0.8 | |
| Inventory Turnover | 1.1 | 1.5 | 1.8 | 2.0 | 1.7 | 1.9 | 2.0 | 1.9 | 2.4 | 2.4 | 1.6 | 3.5 | |
| Receivables Turnover | 6.1 | · | 6.6 | 6.8 | 7.3 | 8.5 | 9.8 | 9.7 | 9.3 | 9.9 | 10.3 | 10.7 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $16.86 | $16.83 | $18.72 | $16.87 | $16.33 | $14.20 | $8.47 | $7.79 | $6.87 | $5.84 | $5.93 | $4.73 | |
| Revenue / Share | $16.13 | · | $12.99 | $14.33 | $11.87 | $9.84 | $10.14 | · | $7.20 | $7.42 | $6.03 | · | |
| Cash Flow / Share | $3.37 | $4.10 | $2.98 | $3.12 | $2.76 | $1.76 | $1.70 | · | $0.45 | $0.90 | $0.70 | · | |
| Cash / Share | $3.86 | $5.99 | $3.30 | $2.27 | $13.09 | $2.29 | $1.87 | $3.21 | $1.33 | $0.96 | $1.55 | $1.04 | |
| EPS (TTM) | $0.16 | $-2.15 | $0.89 | $0.34 | $0.92 | $3.33 | $-0.27 | $-0.01 | $-1.07 | $-1.02 | $0.04 | $-0.39 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 3.6% | 3.9% | 1.2% | 23.1% | 26.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 2.9% | 9.0% | 16.2% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | 161.8% | -63.0% | -72.4% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -22.2% | · | -35.6% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -45.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | 163.7% | -62.1% | -71.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -23.8% | · | -33.9% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -45.4% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $726M | $701M | $675M | $667M | $542M | $430M | $421M | $337M | $287M | $276M | $249M | $198M | |
| Net Income TTM | $7M | $-100M | $42M | $16M | $42M | $146M | $-11M | $-471.0K | $-43M | $-38M | $2M | $-14M | |
| Market Cap | $1.06B | $871M | $1.57B | $1.77B | $2.69B | $2.61B | $1.90B | $1.77B | $1.86B | $1.21B | $2.83B | $3.21B | |
| Enterprise Value | $1.20B | · | · | · | · | · | · | · | · | $1.16B | $2.79B | $3.17B | |
| P/E | 161.8 | -8.8 | 37.9 | 113.6 | 65.4 | 18.0 | -167.8 | -4302.0 | -42.7 | -31.7 | 1919.8 | -227.3 | |
| P/S | 1.5 | 1.2 | 2.3 | 2.7 | 5.0 | 6.1 | 4.5 | 5.3 | 6.5 | 4.4 | 11.4 | 16.2 | |
| P/B | 1.5 | 1.1 | 1.8 | 2.3 | 3.7 | 4.2 | 5.3 | 5.5 | 6.6 | 5.5 | 13.0 | 18.7 | |
| P / Tangible Book | 3.5 | 2.5 | 7.0 | 24.9 | · | 6.2 | · | · | · | · | · | · | |
| P / Cash Flow | 7.0 | 4.6 | 10.1 | 12.2 | 21.4 | 33.9 | 26.9 | 36.3 | 104.4 | 36.2 | 97.6 | 125.8 | |
| P / FCF | 7.8 | 4.9 | 11.2 | 15.4 | 33.7 | 66.6 | 31.5 | 51.6 | -1253.6 | 138.5 | -230.5 | 895.3 | |
| EV / EBITDA | 10.9 | · | · | · | · | · | · | · | · | -60.5 | 133.3 | 650.6 | |
| EV / FCF | 8.8 | · | · | · | · | · | · | · | · | 132.3 | -227.2 | 885.0 | |
| EV / Revenue | 1.6 | · | · | · | · | · | · | · | · | 4.2 | 11.2 | 16.0 | |
| Earnings Yield | 0.62% | -11.4% | 2.6% | 0.88% | 1.5% | 5.6% | -0.60% | -0.02% | -2.3% | -3.2% | 0.05% | -0.44% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $192M | $177M | $197M | $180M | $181M | $169M | $187M | $169M | $178M | $167M | $181M | $164M | $169M | $160M | · | $167M | |
| Cost of Revenue | $44M | $36M | $40M | $34M | $41M | $34M | $40M | $39M | $44M | $47M | $48M | $40M | $48M | $49M | $62M | $51M | |
| R&D Expense | $30M | $28M | $38M | $26M | $28M | $25M | $24M | $19M | $20M | $18M | $19M | $21M | $19M | $17M | $18M | $19M | |
| SG&A Expense | $92M | $94M | $102M | $92M | $89M | $87M | $80M | $74M | $68M | $72M | $66M | $68M | $65M | $71M | $64M | $61M | |
| Operating Expenses | $188M | $170M | $195M | $173M | $173M | $167M | $163M | $308M | $150M | $154M | $148M | $146M | $130M | $163M | · | $146M | |
| Operating Income | $4M | $7M | $2M | $6M | $8M | $2M | $25M | $-140M | $28M | $13M | $33M | $18M | $40M | $-3M | $-10M | $21M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $3M | · | $3M | $4M | $10M | · | $10M | |
| Interest Income | $2M | $2M | $2M | $9M | $5M | $7M | $6M | $5M | $5M | $4M | $3M | $3M | $2M | $3M | $3M | $1M | |
| Other Non-op | $-34.0K | $-135.0K | $-172.0K | $-110.0K | $-11M | $4M | $-53.0K | $-122.0K | $-39.0K | $-159.0K | $515.0K | $-422.0K | $-269.0K | $-10.0K | $81.0K | $-11M | |
| Pretax Income | $3M | $5M | $571.0K | $10M | $-2M | $9M | $26M | $-139M | $37M | $14M | $34M | $17M | $38M | $-26M | $-18M | $2M | |
| Income Tax | $-2M | $2M | $-1M | $4M | $3M | $4M | $9M | $5M | $18M | $5M | $9M | $6M | $12M | $-7M | $-8M | $3M | |
| Net Income | $5M | $3M | $2M | $5M | $-5M | $5M | $16M | $-143M | $19M | $9M | $25M | $11M | $26M | $-20M | $-10M | $-693.0K | |
| EPS (Basic) | $0.12 | $0.07 | $0.05 | $0.12 | $-0.11 | $0.10 | $0.36 | $-3.11 | $0.41 | $0.19 | $0.55 | $0.23 | $0.56 | $-0.43 | $-0.22 | $-0.02 | |
| EPS (Diluted) | $0.12 | $0.07 | $0.05 | $0.12 | $-0.11 | $0.10 | $0.38 | $-3.11 | $0.39 | $0.19 | $0.58 | $0.23 | $0.51 | $-0.43 | $-0.19 | $-0.02 | |
| Shares (Basic) | 39,462,000 | 40,461,000 | · | 44,038,000 | 45,459,000 | 46,275,000 | · | 46,134,000 | 46,174,000 | 46,499,000 | · | 46,416,000 | 46,088,000 | 45,949,000 | · | 45,831,000 | |
| Shares (Diluted) | 40,300,000 | 40,910,000 | · | 44,459,000 | 45,459,000 | 46,526,000 | · | 46,134,000 | 50,539,000 | 52,193,000 | · | 52,067,000 | 52,054,000 | 45,949,000 | · | 45,831,000 | |
| EBITDA | $4M | $28M | · | $6M | $8M | $23M | · | $-140M | $28M | $32M | · | $18M | $40M | $17M | · | $21M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $206M | $144M | $159M | $148M | $300M | $284M | $277M | $246M | $247M | $184M | · | $99M | $87M | $36M | · | $109M | |
| Short-term Investments | $45M | $58M | $80M | $99M | $145M | $210M | $208M | $208M | $157M | $142M | · | $136M | $134M | $138M | · | $219M | |
| Receivables | $132M | $126M | $124M | $115M | $114M | $105M | $113M | $101M | $105M | $102M | · | $97M | $99M | $93M | · | $93M | |
| Inventory | $135M | $150M | $153M | $158M | $148M | $134M | $125M | $112M | $103M | $97M | · | $97M | $92M | $93M | · | $97M | |
| Prepaid Expense | $30M | $37M | $33M | $43M | $37M | $28M | $22M | $24M | $20M | $19M | · | $19M | $17M | $16M | · | $14M | |
| Current Assets | $615M | $515M | $548M | $563M | $746M | $760M | $745M | $690M | $632M | $543M | · | $447M | $429M | $376M | · | $533M | |
| PP&E (Net) | $130M | $136M | $141M | $147M | $155M | $164M | $167M | $167M | $169M | $172M | · | $176M | $180M | $182M | · | $194M | |
| PP&E (Gross) | $281M | $281M | $278M | $280M | $308M | $304M | $300M | $297M | $293M | $292M | · | $307M | $308M | $305M | · | $295M | |
| Accum. Depreciation | $151M | $145M | $138M | $133M | $153M | $140M | $133M | $130M | $124M | $120M | · | $131M | $128M | $123M | · | $102M | |
| Goodwill | $20M | $20M | $20M | $20M | $20M | $22M | $0 | $0 | $163M | $163M | $163M | $163M | $163M | $163M | · | $157M | |
| Intangibles | $285M | $353M | $368M | $382M | $423M | $435M | $426M | $440M | $455M | $469M | · | $498M | $512M | $526M | · | $581M | |
| Total Assets | $1.24B | $1.21B | $1.26B | $1.30B | $1.54B | $1.59B | $1.55B | $1.52B | $1.65B | $1.58B | · | $1.53B | $1.54B | $1.52B | · | $1.73B | |
| Accounts Payable | $18M | $14M | $15M | $18M | $30M | $23M | $19M | $19M | $19M | $9M | · | $17M | $24M | $17M | · | $13M | |
| Accrued Liabilities | $93M | $85M | $96M | $80M | $71M | $80M | $80M | $76M | $65M | $67M | · | $60M | $56M | $62M | · | $76M | |
| Current Liabilities | $122M | $109M | $121M | $107M | $313M | $315M | $310M | $306M | $93M | $93M | · | $94M | $109M | $99M | · | $132M | |
| Capital Leases | $39M | $34M | $36M | $39M | $41M | $44M | $45M | $48M | $50M | $52M | · | $57M | $60M | $62M | · | $65M | |
| Deferred Tax | $4M | $4M | $4M | $5M | $5M | $7M | $0 | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $27M | $25M | $21M | $25M | $25M | $24M | $17M | $13M | $13M | $13M | · | $12M | $12M | $12M | · | $19M | |
| Total Liabilities | $572M | $555M | $572M | $570M | $779M | $788M | $775M | $772M | $768M | $691M | · | $703M | $734M | $755M | · | $964M | |
| Long-term Debt | $363M | $368M | $372M | $377M | $580M | $583M | $585M | · | · | · | · | · | · | · | · | · | |
| Total Debt | $363M | $368M | · | $377M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $49.0K | $48.0K | $48.0K | $48.0K | $48.0K | $47.0K | $47.0K | $47.0K | $47.0K | $47.0K | · | $46.0K | $46.0K | $46.0K | · | $46.0K | |
| Paid-in Capital | $1.09B | $1.07B | $1.06B | $1.05B | $1.04B | $1.02B | $1.01B | $996M | $983M | $990M | · | $963M | $951M | $936M | · | $909M | |
| Retained Earnings | $-192M | $-196M | $-199M | $-201M | $-206M | $-202M | $-206M | $-222M | $-79M | $-98M | · | $-132M | $-143M | $-168M | · | $-139M | |
| Treasury Stock | $227M | $227M | $177M | $126M | $76M | $25M | $25M | $25M | $25M | · | · | · | · | · | · | · | |
| AOCI | $3M | $3M | $4M | $4M | $4M | $1M | $343.0K | $678.0K | $105.0K | $152.0K | · | $-10.0K | $-173.0K | $-137.0K | · | $-670.0K | |
| Stockholders' Equity | $672M | $654M | $693M | $727M | $758M | $799M | $778M | $750M | $879M | $892M | $870M | $832M | $808M | $768M | $775M | $770M | |
| Liabilities + Equity | $1.24B | $1.21B | $1.26B | $1.30B | $1.54B | $1.59B | $1.55B | $1.52B | $1.65B | $1.58B | · | $1.53B | $1.54B | $1.52B | · | $1.73B | |
| Shares Outstanding | 39,822,298 | 39,309,610 | 41,116,739 | 42,965,902 | 44,897,766 | 46,283,407 | 46,240,604 | 46,148,146 | 46,117,359 | 46,517,410 | 46,481,000 | 46,426,836 | 46,408,961 | 45,970,340 | 45,928,000 | 45,864,319 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $21M | $21M | $21M | $21M | $27M | $21M | $21M | $20M | $19M | $18M | $18M | $18M | $19M | $20M | $30M | $20M | |
| Stock-based Comp | $15M | $14M | $13M | $14M | $15M | $15M | $12M | $13M | $13M | $13M | $12M | $13M | $11M | $12M | $13M | $13M | |
| Deferred Tax | · | · | $-4M | $8M | $752.0K | $1M | $4M | $1M | $13M | $3M | $7M | $5M | $11M | $-7M | $-11M | $702.0K | |
| Amort. of Intangibles | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | |
| Restructuring | · | · | $-54.0K | $4M | $0 | $0 | $808.0K | $1M | $996.0K | $6M | $0 | $173.0K | $936.0K | · | $0 | $0 | |
| Other Non-cash | · | $-12M | · | · | · | $-6M | · | · | · | $5M | · | · | · | $14M | · | · | |
| Operating Cash Flow | $57M | $26M | $44M | $61M | $12M | $35M | $33M | $54M | $53M | $49M | $48M | $44M | $43M | $19M | $42M | $43M | |
| CapEx | $1M | $3M | $218.0K | $4M | $3M | $9M | $2M | $4M | $2M | $3M | $2M | $3M | $3M | $7M | $5M | $5M | |
| Investing Cash Flow | $12M | $19M | $19M | $44M | $62M | $-26M | $-368.0K | $-52M | $-15M | $-16M | $8M | $-4M | $7M | $66M | $11M | $-48M | |
| Stock Repurchased | $0 | $50M | $48M | $50M | $50M | $0 | $0 | $0 | · | · | $0 | $0 | · | · | · | · | |
| Net Stock Activity | · | $-50M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-8M | $-59M | $-52M | $-257M | $-58M | $-3M | $-2M | $-3M | $25M | $-3M | $-2M | $-28M | $440.0K | $-154M | $-59M | $-8M | |
| Net Change in Cash | $62M | $-14M | $11M | $-153M | $17M | $7M | $31M | $-1M | $63M | $31M | $54M | $12M | $51M | $-69M | $-5M | $-13M | |
| Taxes Paid | $860.0K | $50.0K | $69.0K | $711.0K | $8M | $286.0K | $1M | $5M | $5M | $-245.0K | $2M | $1M | $594.0K | $201.0K | · | $112.0K | |
| Free Cash Flow | · | $23M | · | · | · | $27M | · | · | · | $46M | · | · | · | $13M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $44M | · | · | · | $5M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.2% | 3.9% | · | 3.5% | 4.7% | 1.2% | · | -82.8% | 15.9% | 7.9% | · | 10.8% | 23.5% | -1.9% | · | 12.7% | |
| Net Margin | 2.4% | 1.6% | · | 3.0% | -2.7% | 2.9% | · | -85.1% | 10.6% | 5.4% | · | 6.6% | 15.2% | -12.2% | · | -0.41% | |
| Pretax Margin | 1.3% | 2.8% | · | 5.3% | -1.1% | 5.1% | · | -82.4% | 20.5% | 8.2% | · | 10.1% | 22.3% | -16.5% | · | 1.2% | |
| EBITDA Margin | 2.2% | 15.9% | · | 3.5% | 4.7% | 13.7% | · | -82.8% | 15.9% | 18.9% | · | 10.8% | 23.5% | 10.3% | · | 12.7% | |
| ROA | 0.33% | 0.21% | · | 0.39% | -0.30% | 0.30% | · | -9.4% | 1.2% | 0.58% | · | 0.66% | 1.6% | -1.1% | · | -0.04% | |
| ROE | 0.65% | 0.40% | · | 0.74% | -0.59% | 0.57% | · | -18.1% | 2.2% | 1.1% | · | 1.4% | 3.3% | -2.6% | · | -0.09% | |
| ROIC | 0.75% | 0.39% | · | 0.33% | 2.8% | 0.14% | · | -19.2% | 1.7% | 0.97% | · | 1.4% | 3.4% | -0.30% | · | -0.93% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 4.7 | · | 5.3 | 2.4 | 2.4 | · | 2.3 | 6.8 | 5.8 | · | 4.8 | 3.9 | 3.8 | · | 4.1 | |
| Quick Ratio | 3.1 | 3.0 | · | 3.4 | 1.8 | 1.9 | · | 1.8 | 5.5 | 4.6 | · | 3.5 | 2.9 | 2.7 | · | 3.2 | |
| Debt / Equity | 0.5 | 0.6 | · | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.5 | 0.6 | · | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 4.0 | · | 5.1 | 10.3 | -0.3 | · | 2.2 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.5 | 0.5 | · | 0.4 | 0.5 | 0.5 | · | 0.6 | |
| Receivables Turnover | 1.6 | 1.5 | · | 1.7 | 1.7 | 1.6 | · | 1.7 | 1.7 | 1.7 | · | 1.7 | 1.8 | 1.7 | · | 2.3 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $16.87 | $16.63 | · | $16.93 | $16.88 | $17.25 | · | $16.24 | $19.07 | $19.18 | · | $17.91 | $17.41 | $16.71 | · | $16.79 | |
| Revenue / Share | $4.77 | $4.34 | · | $4.04 | $3.98 | $3.63 | · | $3.65 | $3.52 | $3.20 | · | $3.15 | $3.26 | $3.49 | · | $3.65 | |
| Cash Flow / Share | · | $0.63 | · | · | · | $0.76 | · | · | · | $0.94 | · | · | · | $0.42 | · | · | |
| Cash / Share | $5.17 | $3.67 | · | $3.44 | $6.69 | $6.13 | · | $5.33 | $5.36 | $3.96 | · | $2.13 | $1.87 | $0.77 | · | $2.39 | |
| EPS (TTM) | $0.36 | $0.13 | · | $0.49 | $-2.74 | $-2.24 | · | $-1.95 | $1.39 | $1.51 | · | $0.12 | $-0.13 | $-0.24 | · | $0.41 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $746M | $735M | · | $717M | $706M | $703M | · | $695M | $690M | $682M | · | · | · | · | · | $654M | |
| Net Income TTM | $15M | $5M | · | $21M | $-127M | $-104M | · | $-91M | $64M | $70M | · | $7M | $-5M | $-10M | · | $21M | |
| Market Cap | $1.01B | $888M | · | $1.11B | $1.07B | $1.15B | · | $695M | $1.32B | $1.36B | · | $1.42B | $1.86B | $1.88B | · | $2.44B | |
| Enterprise Value | $1.12B | $1.05B | · | $1.24B | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | 70.5 | 173.8 | · | 52.6 | -8.7 | -11.1 | · | -7.7 | 20.6 | 19.4 | · | 255.7 | -308.2 | -170.0 | · | 129.7 | |
| P/S | 1.4 | 1.2 | · | 1.5 | 1.5 | 1.6 | · | 1.0 | 1.9 | 2.0 | · | · | · | · | · | 3.7 | |
| P/B | 1.5 | 1.4 | · | 1.5 | 1.4 | 1.4 | · | 0.9 | 1.5 | 1.5 | · | 1.7 | 2.3 | 2.4 | · | 3.2 | |
| P / Tangible Book | 2.8 | 3.2 | · | 3.4 | 3.4 | 3.4 | · | 2.2 | 5.0 | 5.2 | · | 8.3 | 14.0 | 23.9 | · | 76.8 | |
| P / Cash Flow | · | 34.6 | · | · | · | 32.4 | · | · | · | 27.7 | · | · | · | 98.1 | · | · | |
| EV / Revenue | 1.5 | 1.4 | · | 1.7 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 1.4% | 0.58% | · | 1.9% | -11.5% | -9.0% | · | -13.0% | 4.9% | 5.2% | · | 0.39% | -0.32% | -0.59% | · | 0.77% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $726M | $701M | $675M | $667M | $542M |
| Betriebsgewinnmarge % | 2.6% | · | 13.0% | 9.0% | 16.6% |
| Nettoergebnis | $7M | $-100M | $42M | $16M | $42M |
| Verwässerte EPS | $0.16 | $-2.15 | $0.89 | $0.34 | $0.92 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.5 | · | · | · | · |
| Liquiditätsgrad | 4.5 | 2.4 | 5.2 | 3.4 | 1.7 |
| Quick Ratio | 3.0 | 1.9 | 3.9 | 2.6 | 1.4 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $137M | $179M | $139M | $115M | $80M |
Institutionelle Eigentümer (13F) 266 Einreicher · $1.2B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
266
Gehaltener Wert
$1.2B
Neue Positionen
36
Geschlossene Positionen
23
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 36 (0 vs. Vorquartal) | 23 (-16 vs. Vorquartal) | 79 (-8 vs. Vorquartal) | 85 (+5 vs. Vorquartal) | +308K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $170.126.377 | 6.705.809 | 14,10% | Aktien |
| VANGUARD GROUP INC | $124.559.276 | 4.812.955 | 10,32% | Aktien |
| Doma Perpetual Capital Management LLC | $70.472.634 | 2.777.794 | 5,84% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $61.046.258 | 2.406.238 | 5,06% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $53.360.107 | 2.103.245 | 4,42% | Aktien |
| STATE STREET CORP | $52.261.616 | 2.059.977 | 4,33% | Aktien |
| D. E. Shaw & Co., Inc. | $49.479.923 | 1.950.332 | 4,10% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $43.986.531 | 1.733.801 | 3,65% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $42.915.156 | 1.691.571 | 3,56% | Aktien |
| GOLDMAN SACHS GROUP INC | $38.743.263 | 1.527.129 | 3,21% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $29.401.072 | 1.158.693 | 2,44% | Aktien |
| MORGAN STANLEY | $29.039.913 | 1.144.654 | 2,41% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $25.829.019 | 1.018.093 | 2,14% | Aktien |
| UBS Group AG | $23.345.905 | 920.217 | 1,94% | Aktien |
| Impax Asset Management Group plc | $19.028.185 | 750.027 | 1,58% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $18.383.203 | 724.604 | 1,52% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $17.525.241 | 690.786 | 1,45% | Aktien |
| GAGNON SECURITIES LLC | $15.440.613 | 608.617 | 1,28% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $14.294.929 | 563.458 | 1,18% | Aktien |
| NORTHERN TRUST CORP | $13.364.459 | 526.782 | 1,11% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $10.436.533 | 411.373 | 0,87% | Aktien |
| DEUTSCHE BANK AG\ | $9.922.232 | 391.101 | 0,82% | Aktien |
| Jefferies Financial Group Inc. | $9.389.234 | 370.092 | 0,78% | Aktien |
| Hillsdale Investment Management Inc. | $9.201.699 | 362.700 | 0,76% | Aktien |
| Gagnon Advisors, LLC | $8.946.401 | 352.637 | 0,74% | Aktien |
| JPMORGAN CHASE & CO | $8.698.627 | 346.697 | 0,72% | Aktien |
| EASTERLY INVESTMENT PARTNERS LLC | $8.550.172 | 337.019 | 0,71% | Aktien |
| Bridge City Capital, LLC | $7.922.975 | 312.297 | 0,66% | Aktien |
| BARCLAYS PLC | $7.869.496 | 310.189 | 0,65% | Aktien |
| Bank of New York Mellon Corp | $7.531.837 | 296.880 | 0,62% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $7.129.402 | 281.017 | 0,59% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $6.633.164 | 261.457 | 0,55% | Aktien |
| Invesco Ltd. | $6.326.010 | 249.350 | 0,52% | Aktien |
| BANK OF AMERICA CORP /DE/ | $6.088.952 | 240.006 | 0,50% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $5.966.085 | 235.163 | 0,49% | Aktien |
| Coppell Advisory Solutions LLC | $5.592.970 | 16 | 0,46% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $5.562.474 | 219.254 | 0,46% | Aktien |
| FMR LLC | $5.505.316 | 217.001 | 0,46% | Aktien |
| Empowered Funds, LLC | $5.075.852 | 200.073 | 0,42% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $5.068.926 | 199.800 | 0,42% | Aktien |
| ROYAL BANK OF CANADA | $4.704.000 | 185.433 | 0,39% | Aktien |
| Banco Santander, S.A. | $4.211.420 | 166.000 | 0,35% | Aktien |
| Robeco Institutional Asset Management B.V. | $4.161.036 | 164.014 | 0,34% | Aktien |
| AMERIPRISE FINANCIAL INC | $4.137.744 | 163.096 | 0,34% | Aktien |
| CITADEL ADVISORS LLC | $4.114.101 | 162.164 | 0,34% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $4.021.427 | 158.511 | 0,33% | Aktien |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $3.562.811 | 140.434 | 0,30% | Aktien |
| Public Sector Pension Investment Board | $3.429.720 | 135.188 | 0,28% | Aktien |
| PDT Partners, LLC | $3.358.176 | 132.368 | 0,28% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $3.292.062 | 129.762 | 0,27% | Aktien |
Aktivisten & 5%+-Eigentümer 16 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| DOMA PERPETUAL CAPITAL MANAGEMENT LLC, DOMA1 LLC, DOMA Perpetual LO Equity Master Fund LP, DOMA Perpetual Partners GP LLC, Pedro Escudero, The John Templeton Foundation, DOMA2 LLC, Eric de Armas ×4 Einreichungen | 12. März 2026 | 7,30% | Änderung | Vorstandskampagne | SEC |
| Consonance Capital Management LP, Consonance Capman GP LLC, Mitchell Blutt ×5 Einreichungen | 6. September 2019 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 18. März 2014 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 26. Juli 2013 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 2. April 2013 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 21. März 2013 | · | Erste Einreichung | · | SEC |
| Sanderling Venture Partners VI, L.P., Sanderling Ventures Management VI, Sanderling VI Beteiligungs GmbH & Co. KG, Sanderling VI Limited Partnership, Sanderling Venture Partners VI Co-Investment Fund, L.P., Middleton, McNeil, Mills & Associates VI, LLC, Fred A. Middleton ×4 Einreichungen | 21. März 2013 | · | Erste Einreichung | Passive Anlage | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 28. September 2012 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 15. Juni 2012 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 19. März 2012 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 1. Dezember 2011 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 1. Dezember 2011 | · | Erste Einreichung | Passive Anlage | SEC |
| MPM BioVentures IV-QP, L.P., MPM BioVentures IV GmbH & Co. Beteiligungs KG, MPM Asset Management Investors BV4 LLC, MPM BioVentures IV GP LLC, MPM BioVentures IV LLC, Ansbert Gadicke, Luke Evnin, Steven St. Peter, Todd Foley, James Paul Scopa, Vaughn M. Kailian, John Vander Vort | 29. November 2011 | · | Erste Einreichung | Passive Anlage | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 18. Februar 2011 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 18. Februar 2011 | · | Erste Einreichung | · | SEC |
| MPM BioVentures IV Q-P, L.P., MPM BioVentures IV GmbH & Co. Beteiligungs KG, MPM Asset Management Investors BV4 LLC, MPM BioVentures IV GP LLC, MPM BioVentures IV LLC, Ansbert Gadicke, Luke Evnin, Steven St. Peter, William Greene, James Paul Scopa, Ashley Dombkowski, Vaughn M. Kailian, John Vander Vort | 18. Februar 2011 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 44 Insider · 20 Führungskräfte · 17 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Frank D. Lee | Chief Executive Officer | 11. Februar 2026 A | 660.831 | 0 | 0 | $0 |
| David M Stack | CEO and Chairman | 14. Juni 2023 A | 186.481 | 0 | 0 | $0 |
| Shawn Cross | Chief Financial Officer | 23. April 2026 M | 105.341 | 0 | 7 | $-1.521.351 |
| Max Reinhardt | President, Rest of World | 7. Juni 2023 S | 29.225 | 0 | 0 | $0 |
| James S Scibetta | President | 5. Juni 2017 S | 25.118 | 0 | 0 | $0 |
| Scott Braunstein | Chief Operating Officer | 3. Januar 2018 A | 20.982 | 0 | 0 | $0 |
| Jonathan Slonin | Chief Medical Officer | 17. August 2026 S | 216.384 | 0 | 3 | $-240.431 |
| Lauren Riker | Senior Vice President, Finance | 11. Juni 2026 S | 62.284 | 0 | 3 | $-261.266 |
| Kristen Williams | Chief Administrative Officer | 4. Juni 2026 S | 167.062 | 0 | 2 | $-498.171 |
| Brendan Teehan | Chief Commercial Officer | 11. Februar 2026 A | 100.934 | 0 | 0 | $0 |
| Ronald J. Ellis Jr. | Chief Strategy Officer | 7. Juni 2023 S | 30.909 | 0 | 0 | $0 |
| Dennis Mcloughlin | Chief Customer Officer | 7. Juni 2023 S | 38.115 | 0 | 0 | $0 |
| Anthony Molloy | Chief Lgl & Compliance Officer | 6. Juni 2023 S | 12.877 | 0 | 0 | $0 |
| Charles Anthony Laranjeira | Chief Technical Officer | 14. Juni 2022 M | 41.752 | 0 | 0 | $0 |
| Richard Scranton | Chief Scientific Officer | 8. November 2019 M | 16.061 | 0 | 0 | $0 |
| Robert J. Weiland | Chief Commercial Officer | 4. Juni 2018 S | 5.088 | 0 | 0 | $0 |
| James B Jones | SVP & Chief Medical Officer | 20. November 2017 S | 16.823 | 0 | 0 | $0 |
| Taunia Markvicka | SVP, Chief Commercial Officer | 17. März 2015 M | 8.579 | 0 | 0 | $0 |
| Gary Patou | Chief Medical Officer | 7. August 2014 M | 0 | 0 | 0 | $0 |
| John Pratt | General Manager, San Diego | 13. Juni 2013 M | 0 | 0 | 0 | $0 |
| Marcelo Bigal | Direktor | 10. Juni 2026 A | 17.798 | 0 | 0 | $0 |
| Alethia Young | Direktor | 10. Juni 2026 A | 17.798 | 0 | 0 | $0 |
| Christopher Christie | Direktor | 10. Juni 2026 A | 23.059 | 0 | 0 | $0 |
| Samit Hirawat | Direktor | 10. Juni 2026 A | 6.405 | 0 | 0 | $0 |
| Mark Froimson | Direktor | 10. Juni 2026 A | 26.541 | 0 | 1 | $-10.905 |
| Michael J. Yang | Direktor | 10. Juni 2026 A | 19.798 | 0 | 0 | $0 |
| Laura Brege | Direktor | 10. Juni 2026 A | 30.120 | 0 | 0 | $0 |
| Thomas G Wiggans | Direktor | 10. Juni 2026 A | · | 0 | 0 | $0 |
| Mark A. Kronenfeld | Direktor | 11. Juni 2025 A | 31.065 | 0 | 0 | $0 |
| Yvonne Greenstreet | Direktor | 8. Juni 2022 A | 13.247 | 0 | 0 | $0 |
| John P Longenecker PHD | Direktor | 3. März 2022 M | 18.823 | 0 | 0 | $0 |
| Andreas Wicki | Direktor | 15. März 2021 S | 451.324 | 0 | 0 | $0 |
| Dennis L Winger | Direktor | 14. Juni 2017 A | 7.490 | 0 | 0 | $0 |
| Fred A Middleton | Direktor | 24. Juni 2013 S | 0 | 0 | 0 | $0 |
| Luke Evnin | Direktor | 12. Juni 2013 A | 0 | 0 | 0 | $0 |
| HBM Healthcare Investments (Cayman) Ltd. | 10%-Eigentümer | 25. März 2013 S | 2.233.993 | 0 | 0 | $0 |
| Abraham Ceesay | · | 4. September 2025 S | 9.039 | 0 | 0 | $0 |
| Daryl Gaugler | · | 31. Dezember 2024 A | 115.443 | 0 | 0 | $0 |
| Charles A. Reinhart III | · | 12. Juni 2024 A | 51.867 | 0 | 0 | $0 |
| Paul J Hastings | · | 12. Juni 2024 A | 12.724 | 0 | 0 | $0 |
| Gary W Pace | · | 8. März 2024 S | 22.127 | 0 | 0 | $0 |
| Roy Winston | · | 2. August 2023 S | 52.440 | 0 | 0 | $0 |
| Donald C. Manning | · | 9. Juni 2021 A | 29.520 | 0 | 0 | $0 |
| GORDON CARL L | · | 8. Februar 2011 C | 2.828.941 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 58 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1,28% | 10.029 NS | 31. Juli 2026 | N-PORT |
| CAFG · Pacer Funds Trust | 0,74% | 8.394 NS | 31. Juli 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 0,54% | 38.409 SH | 1. Oktober 2026 | Täglich |
| RZG · Invesco Exchange-Traded Fund Trust | 0,50% | 23.694 SH | 1. Oktober 2026 | Täglich |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,50% | 4.607 SH | 1. Oktober 2026 | Täglich |
| XSHQ · Invesco Exchange-Traded Fund Trust … | 0,24% | 27.368 SH | 1. Oktober 2026 | Täglich |
| SCOW · Pacer Funds Trust | 0,23% | 151 NS | 31. Juli 2026 | N-PORT |
| IHE · iShares Trust | 0,23% | 145.471 SH | 11. September 2026 | Täglich |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,18% | 39.523 NS | 31. Juli 2026 | N-PORT |
| CALF · Pacer Funds Trust | 0,15% | 202.699 NS | 31. Juli 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,13% | 42.794 SH | 19. August 2026 | Täglich |
| FSMD · FIDELITY COVINGTON TRUST | 0,11% | 104.986 NS | 31. Juli 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,11% | 30.919 SH | 19. August 2026 | Täglich |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,11% | 46.835 SH | 19. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,08% | 87.939 SH | 1. Oktober 2026 | Täglich |
| DFSV · Dimensional ETF Trust | 0,07% | 231.891 NS | 31. Juli 2026 | N-PORT |
| SMDX · Tidal Trust III | 0,07% | 3.450 NS | 31. Juli 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,07% | 2.809 SH | 1. Oktober 2026 | Täglich |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,06% | 5.956 SH | 1. Oktober 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,06% | 31.734 SH | 19. August 2026 | Täglich |
| ROSC · Lattice Strategies Trust | 0,05% | 1.241 NS | 31. Juli 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,05% | 137.158 SH | 19. August 2026 | Täglich |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,05% | 36.642 SH | 1. Oktober 2026 | Täglich |
| VFQY · VANGUARD WELLINGTON FUND | 0,04% | 7.883 SH | 19. August 2026 | Täglich |
| DFAT · Dimensional ETF Trust | 0,04% | 204.980 NS | 31. Juli 2026 | N-PORT |
| RSSL · Global X Funds | 0,03% | 18.945 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 1.024.328 SH | 11. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 228.207 SH | 19. August 2026 | Täglich |
| PKW · Invesco Exchange-Traded Fund Trust | 0,03% | 19.840 SH | 1. Oktober 2026 | Täglich |
| EBIT · Harbor ETF Trust | 0,02% | 106 NS | 31. Juli 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,02% | 542.974 SH | 19. August 2026 | Täglich |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,02% | 2.098 SH | 1. Oktober 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,02% | 90.095 NS | 31. Juli 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 17.794 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 453.622 SH | 19. August 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,01% | 854.717 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 112.735 SH | 19. August 2026 | Täglich |
| TILT · FlexShares Trust | 0,01% | 7.900 NS | 31. Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 2.019 SH | 11. September 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,01% | 118.628 NS | 31. Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 1.277 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 6.433 NS | 31. Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,01% | 28.461 SH | 11. September 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,00% | 9.932 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 69.932 SH | 11. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 12.671 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 12.150 SH | 11. September 2026 | Täglich |
| DFUV · Dimensional ETF Trust | 0,00% | 866 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.198.792 SH | 19. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.506 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.388 SH | 19. August 2026 | Täglich |
| IJR · iShares Trust | · | 2.397.496 SH | 10. September 2026 | Täglich |
| IJT · iShares Trust | · | 374.609 SH | 9. September 2026 | Täglich |
| IWN · iShares Trust | · | 338.098 SH | 11. September 2026 | Täglich |
| XJR · iShares Trust | · | 5.453 SH | 31. August 2026 | Täglich |
| ISCB · iShares Trust | · | 1.678 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 8.216 SH | 11. September 2026 | Täglich |
| SMMV · iShares Trust | · | 12.184 SH | 19. August 2026 | Täglich |
PCRX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 13 Analysten
KAUF
Median-Ziel
$30.00
+19,0%
3 23,1%
Starker Kauf
6 46,2%
Kauf
3 23,1%
Halten
1 7,7%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
9 Analysten · 2026-10-01Mittelwert-Ziel $30.00 +19,0%
Jetzt
Aktueller Preis $25.21
Tief$23.00
Mittelwert$30.00
Hoch$38.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| PCRX | $1.06B | 161.8 | 3.6% | 0.97% | 0.97% | · |
| HROW | $1.82B | -350.0 | 36.4% | -1.9% | -8.4% | 75.0% |
| YARW | · | · | · | · | · | · |
| AMPH | $1.22B | 13.2 | -1.7% | 13.6% | 12.7% | 49.5% |
| SPTX | · | · | · | · | · | · |
| ANRO | $568M | -8.1 | · | · | -46.1% | · |
| ALMS | · | -3.4 | · | -1011.8% | -61.9% | · |
| APMD | · | · | · | · | · | · |
| SGP | · | · | · | · | 50.0% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 4, 2026